Back to search

Article

Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How We Can Account for Histocompatibility and Disease Specificity of MSC EV Treatments

2025-05-12

Abstract excerpt

The central hypothesis presented here is that released extracellular vesicles (EVs) can act primarily on targeted cells to induce the production of secondary EVs to mediate the final biological events. Compared here are different instances. In one, EVs, primarily produced by CD8+ suppressor T cells, are activated in immune tolerance. These EVs transfer to companion recipient macrophages (Macs) the ability to gener...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d611a0c-76f0-5726-942d-26beb483c756
DOI
10.20944/preprints202505.0896.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How We Can Account for Histocompatibility and Disease Specificity of MSC EV TreatmentsDOI 10.20944/preprints202505.0896.v1
Select a neighboring publication to make it the new centre.